Results 161 to 170 of about 15,160 (239)
Objective Proteome‐wide risk models for lupus remain underexplored. We developed classification models to identify lupus from serum proteomic profiles. Methods Patients with lupus and individuals with other autoimmune diseases in the UK Biobank were included.
Mehmet Hocaoǧlu +2 more
wiley +1 more source
Regulation of cancer cell adhesion, progression, and epithelial-to-mesenchymal transition by N-glycosylation. [PDF]
Gu J.
europepmc +1 more source
Role of selectins and their receptors in the regulation of the haemopoietic system
The production of blood cells occurs in the bone marrow. This process depends on the controlled proliferation and development of rare and multipotent precursors called haemopoietic stem cells, and involves a subtle balance between the positive regulation
core
ABSTRACT Atherosclerosis is driven by coordinated changes in endothelial cells (ECs), macrophages, and vascular smooth muscle cells (VSMCs). Post‐translational modifications (PTMs), phosphorylation, acetylation, ubiquitination, SUMOylation, O‐GlcNAcylation, palmitoylation, ISGylation, and ADP‐ribosylation, integrate metabolic, inflammatory, and ...
Weiwei Jiang, Haiping Du
wiley +1 more source
No-reflow in acute ischemic stroke: mechanisms, measurements, and molecular markers. [PDF]
Bayona H, Granja MF, Useche JN.
europepmc +1 more source
Anti‐Inflammatory Therapies in Coronary Artery Disease; A Systematic Review
This review explores the evidence for anti‐inflammatory medications in prevention of MACE, effects on radiographic measurements of coronary disease, and prevention of reperfusion injury when administered in the acute setting. Of particular note are the trials concerning medications targeting the NLRP3 inflammasome pathway and its downstream products ...
Louis de Courcy, Jack Moore
wiley +1 more source
Capillary stalling after traumatic brain injury: an emerging microcirculatory contributor to secondary brain injury. [PDF]
Lei X, Yang Y, Yang X, Tao K.
europepmc +1 more source
Demonstrating pharmacological effects in early‐phase oncology clinical trials remains challenging, largely due to the lack of robust pharmacodynamic markers. Lipopolysaccharide (LPS) is used as an immune challenge agent in healthy participants to study drugs for autoimmune conditions.
Igor Radanović +11 more
wiley +1 more source
From Glycocode to Precision Oncology: Therapeutic Strategies Targeting Aberrant O-GalNAc Glycosylation in Cancer. [PDF]
Aasted MKM +5 more
europepmc +1 more source
This review offers a thorough examination of the therapeutic uses of hesperidin, emphasizes significant findings from structure‐activity relationship research, and addresses recent advancements in the synthesis and biological assessment of hesperidin analogs.
Mohammadsaeed Kordi +5 more
wiley +1 more source

